S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
Log in

NASDAQ:NATR - Nature's Sunshine Products Stock Price, Forecast & News

$8.30
+0.47 (+6.00 %)
(As of 03/30/2020 04:00 PM ET)
Today's Range
$8.00
Now: $8.30
$8.39
50-Day Range
$6.11
MA: $8.82
$10.85
52-Week Range
$5.50
Now: $8.30
$10.85
Volume13,438 shs
Average Volume19,745 shs
Market Capitalization$161.63 million
P/E Ratio23.71
Dividend YieldN/A
Beta0.79
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia; Central and Eastern Europe; and NSP China. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Read More

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
SectorMedical
Current SymbolNASDAQ:NATR
CUSIP63902710
Phone801-341-7900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$362.21 million
Cash Flow$1.03 per share
Book Value$6.70 per share

Profitability

Net Income$6.76 million

Miscellaneous

Employees905
Market Cap$161.63 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive NATR News and Ratings via Email

Sign-up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.


Nature's Sunshine Products (NASDAQ:NATR) Frequently Asked Questions

How has Nature's Sunshine Products' stock been impacted by COVID-19 (Coronavirus)?

Nature's Sunshine Products' stock was trading at $7.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NATR shares have increased by 6.5% and is now trading at $8.30. View which stocks have been mosted impacted by Coronavirus.

When is Nature's Sunshine Products' next earnings date?

Nature's Sunshine Products is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Nature's Sunshine Products.

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products (NASDAQ:NATR) announced its quarterly earnings data on Wednesday, March, 11th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $91.70 million for the quarter. Nature's Sunshine Products had a net margin of 1.87% and a return on equity of 6.35%. View Nature's Sunshine Products' earnings history.

Has Nature's Sunshine Products been receiving favorable news coverage?

News articles about NATR stock have trended somewhat negative on Monday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nature's Sunshine Products earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View the latest news aboutNature's Sunshine Products.

Are investors shorting Nature's Sunshine Products?

Nature's Sunshine Products saw a increase in short interest in March. As of March 13th, there was short interest totaling 95,800 shares, an increase of 25.6% from the February 27th total of 76,300 shares. Based on an average daily trading volume, of 21,300 shares, the days-to-cover ratio is presently 4.5 days. Currently, 0.6% of the company's shares are short sold. View Nature's Sunshine Products' Current Options Chain.

Who are some of Nature's Sunshine Products' key competitors?

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), AT&T (T), Catalyst Pharmaceuticals (CPRX), Gilead Sciences (GILD), AbbVie (ABBV), Bausch Health Companies (BHC), NovaBay Pharmaceuticals (NBY), Akorn (AKRX), Accelerate Diagnostics (AXDX) and Concert Pharmaceuticals (CNCE).

Who are Nature's Sunshine Products' key executives?

Nature's Sunshine Products' management team includes the following people:
  • Mr. Terrence O. Moorehead, Pres, CEO & Director (Age 56)
  • Mr. Joseph W. Baty, Exec. VP, CFO & Treasurer (Age 62)
  • Ms. Susan M. Armstrong, Exec. VP & COO (Age 54)
  • Ms. Adriana G. Mendizábal, Chief Marketing Officer
  • Mr. Nathan G. Brower, Exec. VP, Gen. Counsel & Sec. (Age 39)

What is Nature's Sunshine Products' stock symbol?

Nature's Sunshine Products trades on the NASDAQ under the ticker symbol "NATR."

Who are Nature's Sunshine Products' major shareholders?

Nature's Sunshine Products' stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (2.91%), First Wilshire Securities Management Inc. (2.56%), State Street Corp (0.92%), Geode Capital Management LLC (0.48%), Copperwynd Financial LLC (0.37%) and Panagora Asset Management Inc. (0.26%). Company insiders that own Nature's Sunshine Products stock include Kristine F Hughes and Wynnefield Partners Small Cap. View institutional ownership trends for Nature's Sunshine Products.

Which institutional investors are selling Nature's Sunshine Products stock?

NATR stock was sold by a variety of institutional investors in the last quarter, including First Wilshire Securities Management Inc., Nuveen Asset Management LLC, and Copperwynd Financial LLC. View insider buying and selling activity for Nature's Sunshine Products.

Which institutional investors are buying Nature's Sunshine Products stock?

NATR stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Alambic Investment Management L.P., Mackay Shields LLC, US Bancorp DE, UBS Group AG, Jacobs Levy Equity Management Inc., State Street Corp, and Barclays PLC. View insider buying and selling activity for Nature's Sunshine Products.

How do I buy shares of Nature's Sunshine Products?

Shares of NATR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nature's Sunshine Products' stock price today?

One share of NATR stock can currently be purchased for approximately $8.30.

How big of a company is Nature's Sunshine Products?

Nature's Sunshine Products has a market capitalization of $161.63 million and generates $362.21 million in revenue each year. Nature's Sunshine Products employs 905 workers across the globe. View additional information about Nature's Sunshine Products.

What is Nature's Sunshine Products' official website?

The official website for Nature's Sunshine Products is http://www.naturessunshine.com/.

How can I contact Nature's Sunshine Products?

Nature's Sunshine Products' mailing address is 2901 WEST BLUEGRASS BOULEVARD SUITE 100, LEHI UT, 84043. The company can be reached via phone at 801-341-7900 or via email at [email protected]


MarketBeat Community Rating for Nature's Sunshine Products (NASDAQ NATR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  145 (Thanks for Voting!)
Underperform Votes:  171 (Thanks for Voting!)
Total Votes:  316
MarketBeat's community ratings are surveys of what our community members think about Nature's Sunshine Products and other stocks. Vote "Outperform" if you believe NATR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NATR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel